Milan, Italy, November 30th, 2023 – Dedalus Group (“Dedalus”), the leading anatomic pathology information systems provider in Europe, and Ibex... View Article
The HITRUST Certification Validates Ibex’s Commitment to Strong Cybersecurity and Meeting Key Regulations to Protect Sensitive Data Boston, Massachusetts –... View Article
Roche’s navify Digital Pathology software platform now offers Ibex’s Artificial Intelligence (AI) algorithms to support clinicians in the diagnosis of... View Article
More Than 10,000 Patient Cases Diagnosed Using Ibex’s AI Platform; CorePlus Expands its AI Deployment to Primary Diagnosis CAROLINA, Puerto... View Article
Developed in Collaboration with AstraZeneca and Daiichi Sankyo, Galen™ Breast HER2 Aids Pathologists with Reproducible HER2 Assessment TEL AVIV –... View Article
Led by 83North, This Round of Financing Brings Total Funding to Over $100 Million TEL AVIV – September 6, 2023... View Article
Alverno Strengthens Its Diagnostics Portfolio and Deploys Ibex’s Suite of AI Solutions, Bringing Improved Cancer Care for Patients Across Its... View Article
NHS Expands Access to Ibex’s Galen™ Breast and Galen™ Prostate Solutions to 25 Trusts Across the UK Following PathLAKE Plus... View Article
NHS Invests £123 million in AI, Accelerating Nationwide Adoption Including Deployment of Ibex’s Galen™ Breast Solution Across Five NHS Trusts... View Article
Pathology Diagnostics Platform Meets Safety, Quality and Performance Criteria Under EU’s New In Vitro Diagnostic Medical Devices Regulation Tel Aviv,... View Article
Ibex’s AI Algorithm to Aid Pathologists with Accurate and Reproducible HER2 and HER2-low Assessment in Breast Cancer Diagnosis Tel Aviv,... View Article
The Study, conducted at Institut Curie and Maccabi Healthcare Services, demonstrated very high accuracy for Ibex AI in detecting breast... View Article
